Adaptive Biotechnologies Corp (ADPT) experienced a significant pre-market plunge of 10.40% on Thursday, as traders reacted ahead of the company's scheduled quarterly earnings report.
The sharp decline comes as the company is set to report its fourth-quarter results later in the day. According to earnings estimates, analysts expect Adaptive Biotechnologies to post a loss of $0.19 per share for the quarter, contributing to negative sentiment in pre-market trading.